Skip to main content
Year archive

Immunovia — 2021 filings

All 23 regulatory filings released by Immunovia (IMMNOV) in 2021, sourced directly from the official regulator.

23 Filings
2021 Period
2021 filings (23)
Filing Released Lang
Immunovia’s CEO to step down during 2022
Board/Management Information
2021-11-30 English
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-11 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-11 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-05-20 English
Kommuniké från årsstämma i Immunovia AB
AGM Information
2021-05-06 Swedish
Annual General Meeting - Immunovia AB
AGM Information
2021-05-06 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-04-29 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-28 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-28 English
Immunovia presenterar uppdatering av marknadens storlek i USA för IMMray® PanCan-d i den familjära/ärftliga riskgruppen
Regulatory Filings
2021-04-21 Swedish
Immunovia presents update on US market size for IMMray™ PanCan-d in the familial/hereditary risk group
Regulatory Filings
2021-04-21 English
KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB
AGM Information
2021-03-31 Swedish
Immunovia reports improved test performance of IMMray[TM] PanCan-d in detecting early stage pancreatic cancer in high risk symptomatic patients
Regulatory Filings
2021-03-29 English
Immunovia rapporterar förbättrad testprestanda för IMMray ® PanCan-d för upptäckt av bukspottkörtelcancer i tidigt stadium hos högriskpatienter med symptom
Earnings Release Q1 2021
2021-03-29 Swedish
Immunovia reports positive results of the blinded clinical validation of IMMray[TM] PanCan-d blood test in USA
Earnings Release FY 2021
2021-03-29 English
Immunovia rapporterar positiva resultat för IMMray ® PanCan-d blodbaserade test i blindad klinisk valideringsstudie utförd i USA
Regulatory Filings
2021-03-29 Swedish
Audit Report / Information 2020
Audit Report / Information FY 2020
2021-03-12 Swedish
Annual Report 2020
Annual Report FY 2020
2021-03-12 English
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-17 Swedish
Audit Report / Information 2020
Audit Report / Information FY 2020
2021-02-17 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-15 English